The Icahn School of Medicine at Mount Sinai (ISMMS), formerly Mount Sinai School of Medicine, is a medical school in New York City, New York.
The Latest Bing News on:
Icahn School of Medicine at Mount Sinai (ISMMS) Research
- Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2022
Continued KidneyIntelX testing volume growth Over 3,000 KidneyIntelX risk scores generated for Mount Sinai Health System patients and over 300 at Wake Forest Baptist Health 33 state Medicaid ...
- Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2022
LONDON and SALT LAKE CITY, June 30, Jun 30, 2022 (GLOBE NEWSWIRE via COMTEX) -- LONDON and SALT LAKE CITY, June 30, 2022 (GLOBE NEWSWIRE) -- Renalytix plc ...
- Renalytix AI plc (“RenalytixAI” or the “Company”) Full Year Report
RenalytixAI is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the most common and costly chronic medical conditions ... of ...
- Renalytix AI plc (“RenalytixAI” or the “Company”) Full Year Report
RenalytixAI is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the most common and costly chronic medical conditions ... of ...
- Microbiology Virtual Week 2021
Labroots is excited to bring academia and industry, research experts, virologists, microbiologists, healthcare professionals, and leading biomedical scientists under one roof at our 7th Annual ...
The Latest Google Headlines on:
Icahn School of Medicine at Mount Sinai (ISMMS) Research
The Latest Bing News on:
Icahn School of Medicine at Mount Sinai (ISMMS) Discovery
- Phenotypic screen with deep learning finds cardioprotective molecules
so here we allowed a deep learning algorithm to guide us early in the discovery process,” explains lead author Mohammad Mandegar from Tenaya Therapeutics. The investigators screened a library of ...
- Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2022
Continued KidneyIntelX testing volume growth Over 3,000 KidneyIntelX risk scores generated for Mount Sinai Health System patients and over 300 at Wake Forest Baptist Health 33 state Medicaid ...
- Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2022
LONDON and SALT LAKE CITY, June 30, Jun 30, 2022 (GLOBE NEWSWIRE via COMTEX) -- LONDON and SALT LAKE CITY, June 30, 2022 (GLOBE NEWSWIRE) -- Renalytix plc ...
- Renalytix AI plc (“RenalytixAI” or the “Company”) Full Year Report
RenalytixAI is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the most common and costly chronic medical conditions ... of ...
- Renalytix AI plc (“RenalytixAI” or the “Company”) Full Year Report
RenalytixAI is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the most common and costly chronic medical conditions ... of ...